Cambridge Cognition Holdings plc (COG) Ordinary 1p

Cambridge Cognition Holdings plc is a United Kingdom-based brain health software company, which is engaged in developing and marketing digital solutions to assess brain health, principally in the United Kingdom, the United States and Europe. Its products include CANTAB, Electronic Clinical Outcomes Assessment (eCOA), NeuroVocalix, Winterlight, Cognition Kit, Clinpal, eConsent, and AQUA. CANTAB Connect gives the control to manage and deliver a battery of touchscreen and voice assessments, as well as fully customizable electronic questionnaires and scales. Cognition Kit is a custom-designed digital health platform delivering wearable and smartphone apps for high frequency data collection. The Company’s therapeutic areas include attention deficit hyperactivity disorder (ADHD), Alzheimer’s Disease, Autism Spectrum Disorder, Depression, Down’s Syndrome, Drug Abuse Liability, Epilepsy, Parkinson’s Disease, Stroke and Cerebrovascular Disease, and Traumatic Brain Injury, among others.